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A B S T R A C T
In allergic disease, mast cell activation is conventionally triggered by allergen-mediated cross-linking of re-
ceptor-bound IgE on the cell surface. In addition to its diverse range of intracellular roles in apoptosis, cell
proliferation and cancer, Histamine-Releasing Factor (HRF) also activates mast cells and basophils. A subset of
IgE antibodies bind HRF through their Fab regions, and two IgE binding sites on HRF have been mapped. HRF
can form dimers, and a disulphide-linked dimer is critical for activity. The current model for the activity of HRF
in mast cell activation involves cross-linking of receptor-bound IgE by dimeric HRF, mediated by HRF/Fab
interactions. HRF crystal and solution structures have provided little insight into either the formation of dis-
ulphide-linked HRF dimers or the ability of HRF to activate mast cells. We report the ﬁrst crystal structure of
murine HRF (mHRF) to 4.0 Å resolution, revealing a conserved fold. We also solved the structure of human HRF
(hHRF) in two new crystal forms, one at the highest resolution (1.4 Å) yet reported. The high resolution hHRF
structure reveals a disulphide-linked dimer, in which the two molecules are closely associated, and provides a
model for the role of both human and murine HRF in mast cell activation.
1. Introduction
Histamine-Releasing Factor (HRF), also referred to as
Translationally Controlled Tumour Protein (TCTP), p21, p23 and for-
tilin, is ubiquitously expressed in eukaryotes, and involved in apoptosis,
cell cycle progression, cell proliferation and cancer (Bommer and
Thiele, 2004; Nagano-Ito and Ichikawa, 2012; Bommer, 2012). In ad-
dition to its diverse range of intracellular roles, HRF is also able to
activate mast cells and basophils, with the release of histamine
(MacDonald et al., 1995; Kashiwakura et al., 2012), implicating a role
in allergic disease. Mast cell activation is conventionally triggered by
allergen-mediated cross-linking of FcεRI-bound IgE on the cell surface
(Gould and Sutton, 2008). Studies of murine HRF (mHRF), which is
96% identical to human HRF (hHRF), revealed that a subset of IgE
antibodies bound to mHRF through their Fab regions, and two IgE
binding sites on HRF were mapped, one to the N-terminus (residues
1–19) and another to a helical region (residues 107–135) (Kashiwakura
et al., 2012). HRF can form dimers (Yoon et al., 2000; Kim et al., 2009;
Kashiwakura et al., 2012), and a disulphide-linked dimer was shown to
be crucial for the cytokine-like activity of rat HRF (Kim et al., 2009).
mHRF, hHRF and rat HRF contain two cysteine residues, at positions 28
and 172, and Cys172 is suggested to be the site of the intermolecular
disulphide bond (Kim et al., 2009).
The current model for the activity of HRF in mast cell activation
involves cross-linking of FcεRI-bound IgE by dimeric HRF, mediated by
interactions between HRF and the Fab regions of IgE (Kawakami et al.,
2014). HRF crystal structures have revealed diﬀerent packing ar-
rangements, but provided little insight into the formation of dimers,
particularly those linked by a disulphide bond. Crystal structures for
HRF from Plasmodium knowlesi (Vedadi et al., 2007) and Plasmodium
falciparum (Eichhorn et al., 2013) contain monomers in their asym-
metric units; both proteins contain a cysteine residue which is buried
and thus incapable of forming a disulphide-linked dimer. Likewise, the
solution structure of HRF from Schizosaccharomyces pombe (Thaw et al.,
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2001) comprises a monomer, and the side chain of the single cysteine
residue is buried. Although HRF from Caenorhabditis elegans contains
two cysteine residues which are surface exposed, the solution structure
also comprises a monomer (Lange et al., 2012). The solution structure
of hHRF (Feng et al., 2007) also reveals a monomeric structure, and one
crystal structure contains four molecules in the asymmetric unit (Susini
et al., 2008) which form only non-covalent interactions with one an-
other. To date, a single crystal structure of an hHRF Glu12Val mutant
has revealed a disulphide-linked dimer, mediated by Cys172 (Dong
et al., 2009), but the two monomers are not closely associated with one
another, and the C-terminal puriﬁcation tag of the construct contributes
a substantial portion of the dimer interface.
We report here the ﬁrst crystal structure of murine HRF (mHRF),
solved at 4.0 Å resolution, revealing the conserved HRF fold. We also
report two structures of human HRF (hHRF) in new crystal forms, one of
which was solved at the highest resolution yet reported (1.4 Å) for HRF.
One hHRF structure, and the mHRF structure, contain non-covalent HRF
interactions, but reveal diﬀerent packing arrangements. However, the
high resolution hHRF structure reveals a disulphide-linked HRF dimer,
with substantial contact between the two monomers, ﬁnally providing a
model for the activity of dimeric HRF in allergic disease.
2. Materials and methods
2.1. Protein preparation and crystallisation
mHRF and hHRF were prepared according to a previously described
protocol (Kashiwakura et al., 2012). Both proteins include a C-terminal
His-tag for puriﬁcation. mHRF crystals were grown at 18 °C using the
sitting drop vapour diﬀusion method, with a reservoir volume of 70 μL
and drops comprising 100 nL protein (4.7 mg/mL) and 50 nL reservoir.
mHRF crystals were grown in 0.1 M Tris-HCl pH8.4, 23% (w/v) PEG
2000 MME and 0.01 M nickel chloride, and were cryoprotected in
0.1 M Tris-HCl pH8.4, 23% (w/v) PEG 2000 MME, 0.01 M nickel
chloride and 20% (v/v) glycerol. hHRF crystals were grown at 18 °C
using the sitting drop vapour diﬀusion method, with a reservoir volume
of 50 μL and drops comprising 120 nL protein (10 mg/mL) and 120 nL
reservoir. hHRF-1 crystals were grown in 0.1 M MMT pH4.0 and 25%
(w/v) PEG 1500, and were cryoprotected using the mother liquor.
hHRF-2 crystals were grown in 0.1 M MES pH6.0 and 20% (w/v) PEG
2000 MME and were also cryoprotected using the mother liquor.
2.2. Structure determination, model building and reﬁnement
Data were collected at beamlines I04 (mHRF), I03 (hHRF-1) and
I04-1 (hHRF-2) at the Diamond Light Source (Harwell, UK). Data were
integrated with XDS (Kabsch, 2010) or DIALS (Waterman et al., 2013)
within the xia2 program (Winter, 2010), and scaled with AIMLESS
(Evans and Murshudov, 2013) from the CCP4 suite (Winn et al., 2011).
The mHRF crystals diﬀracted anisotropically, and the data were trun-
cated to resolution limits of 4.2 Å, 4.5 Å and 4.0 Å using the UCLA
Diﬀraction Anisotropy Server (Strong et al., 2006). mHRF and hHRF
structures were solved by molecular replacement with PHASER (McCoy
et al., 2007) using PDB 1YZ1 (Susini et al., 2008) as a search model. For
all structures, reﬁnement was performed with PHENIX (Adams et al.,
2010) and manual model building with Coot (Emsley et al., 2010). Data
processing and reﬁnement statistics are presented in Table 1. Interfaces
were analysed with PISA (Krissinel and Henrick, 2007) and ﬁgures were
prepared with PyMOL (Version 1.8.2.1 Schrödinger, LLC).
3. Results and discussion
We report here the ﬁrst crystal structure of mHRF at 4.0 Å resolu-
tion, and two structures of hHRF (hHRF-1 and hHRF-2) in new crystal
forms, the latter revealing a disulphide-linked dimer.
3.1. Overall structure of mHRF
The structure of mHRF was solved at 4.0 Å resolution, and contains
two molecules in the asymmetric unit (Fig. 1A). Residues 1–38 and
68–170, and 1–41 and 67–170 were modeled for chains A and B, re-
spectively; similar to other crystal structures of HRF (Vedadi et al.,
2007; Susini et al., 2008; Dong et al., 2009; Eichhorn et al., 2013), the
mobile loop region (residues Thr39-Val66) was disordered. mHRF
contains a C-terminal His-tag, which was also disordered; a substantial
region of continuous electron density was observed close to the C-ter-
minus, but the tag could not be modeled with certainty.
The overall fold of mHRF is conserved, and comprises three α-he-
lices packed against two β-sheets, while a third β-sheet forms the base
of the mobile loop (Fig. 1B). Consistent with a conserved fold, the in-
dividual monomers of the mHRF asymmetric unit were superposed on
HRF crystal structures (H. sapiens, P. falciparum and P. knowlesi) (Vedadi
et al., 2007; Susini et al., 2008; Dong et al., 2009; Eichhorn et al., 2013)
with RMSD values for Cα atoms ranging from 0.52-1.22 Å, and on HRF
solution structures (C. elegans, H. sapiens and S. pombe) (Thaw et al.,
2001; Feng et al., 2007; Lange et al., 2012) with RMSD values ranging
from 1.16-3.23 Å.
Like hHRF, mHRF contains two cysteine residues at positions 28 and
172, and thus has the potential to form a covalently-linked dimer; while
Cys28 is buried, Cys172 is surface exposed. However, the two molecules
of the mHRF asymmetric unit, which are related by non-crystallographic
two-fold symmetry, form only non-covalent interactions (Fig. 1A). The
two molecules bury a surface area of 176 Å2 at their interface, in which
Glu80-Thr84 from one chain pack against equivalent residues from the
other, with a hydrogen bond between Ser82 from each chain (Fig. 1C). A
similar interface is found in two previously reported hHRF structures
Table 1
Data processing and reﬁnement statistics.
Data processing mHRF hHRF-1 hHRF-2
Space group P 21 21 2 P 1 21 1 P 21 21 21
Unit cell dimensions (Å) a= 69.53 a= 49.73 a= 47.53
b= 99.85 b = 58.95 b= 77.59
c= 57.47 c = 57.73 c= 99.32
β= 99.41°
Resolution (Å)
Overall 57.06−4.01 24.53−1.75 19.86−1.40
(outer shell) (4.63−4.01) (1.78−1.75) (1.43−1.40)
Completeness (%)a 98.5 (95.8) 99.3 (97.3) 99.7 (99.6)
Multiplicitya 11.6 (12.0) 4.5 (3.4) 7.4 (7.6)
Mean ((I)/σ(I))a 9.0 (2.1) 11.7 (1.8) 12.7 (1.9)
Rmerge a 0.271 (1.892) 0.124 (1.085) 0.066 (1.112)
Rpim a 0.081 (0.554) 0.065 (0.667) 0.025 (0.428)
CC1/2 a 0.997 (0.877) 0.988 (0.342) 0.999 (0.703)
Wilson B-factor (Å2) 233 15.9 15.1
Reﬁnement
Rwork/Rfree (%)b 29.96/34.16 18.84/22.09 17.93/19.85
No. of reﬂections 3 125c 32 846 72 706
RMSD
Bond lengths (Å) 0.001 0.004 0.015
Bond angles (°) 0.361 0.632 1.546
Coordinate error (Å) 0.48 0.20 0.14
No. of atoms
Protein 2 159 2 564 2 581
Solvent 0 215 301
Other 6d 0 5e
Ramachandran plot
Favoured (%) 97.12 99.05 98.48
Allowed (%) 100 100 100
a Values in parentheses are for the highest resolution shell.
b Rfree set comprises 5% of reﬂections.
c Data were truncated to resolution limits of 4.2 Å, 4.5 Å and 4.0 Å.
d Glycerol.
e Polyethylene glycol.
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[PDB 1YZ1 (Susini et al., 2008) and PDB 3EBM (Dong et al., 2009)];
however, the molecules in these two structures are more closely asso-
ciated with one another (Fig. 1D), and the interface buries a surface area
of up to 346 Å2. Lys130 plays a key role at this interface: Lys130 from
one chain contacts Lys130, Asn131 or Gln133 from the other. By con-
trast, these interactions are precluded in mHRF, as not only do the
overall positions of the two molecules diﬀer, but residue 130 is one of the
seven positions at which the mHRF and hHRF sequences diverge (Asn130
in mHRF/Lys130 in hHRF).
3.2. Overall structure of hHRF-1
The structure of hHRF-1, solved at 1.75 Å resolution, contains two
molecules in the asymmetric unit (Fig. 2A). Residues 1–41 and 62–180,
and 1–40 and 64–180 were modeled for chains A and B of the hHRF-1
structure, respectively, and as in the mHRF structure, a substantial
portion of the mobile loop region was disordered.
The two molecules of the asymmetric unit form non-covalent in-
teractions, and are arranged such that their interface buries a surface
area of∼530 Å2 (Fig. 2B). This particular packing arrangement is very
diﬀerent to that of mHRF, and has not been observed in any other HRF
crystal structure. The interface includes the following interactions:
Glu40, Thr65 and Ile67 (chain A) pack against Thr116 (chain B); Gln79
(chain A) forms a hydrogen bond with Glu120 (chain B), and together
with Glu80 (chain A) contacts Asp25 (chain B), which also forms a
hydrogen bond with the Gln80 (chain A) main chain; Ser82 (chain A)
contacts Glu22 (chain B), and a water molecule forms a bridging hy-
drogen bond with the Glu22 main chain; Asn139 (chain A) contacts
His124 (chain B), and a water molecule forms a bridging hydrogen
bond between the Asn139 main chain and His124 side chain; Met140
(chain A) contacts Ile23, Ala24, Gln121 and His124 (chain B), and the
Met140 main chain forms a hydrogen bond with Arg21 (chain B);
Pro142 (chain A) packs against Arg21 and Arg152 (chain B).
3.3. Overall structure of hHRF-2
The structure of hHRF-2 was solved at 1.4 Å resolution, the highest
reported to date for HRF, and contains two molecules in the asymmetric
unit (Fig. 3A). Residues 1–41 and 63–178, and 1–37 and 50–177 were
modeled for chains A and B of the hHRF-2 structure, respectively. There
is an extensive dimer interface of ∼954 Å2, which will be discussed in
detail in the following section.
In HRF crystal and solution structures, the base of the mobile loop
consists of two strands of β-sheet, and the overall position of this sheet
Fig. 1. mHRF. (A) Overall structure of mHRF solved at 4.0 Å resolution. The two molecules of the asymmetric unit are coloured pink and green, and the positions of the N- and C-terminal
residues, and residues adjacent to the disordered loop, are indicated. (B) The overall fold of mHRF is conserved. The solution structure (grey) (Feng et al., 2007) and a crystal structure
(orange) (Susini et al., 2008) of human HRF are superposed on chain A from the mHRF crystal structure (purple). The three α-helices are labeled, and the positions of the N- and C-
terminal residues, and residues adjacent to the disordered loop, are indicated. For clarity, the mobile loop from the solution structure is not shown. (C) Interface between Glu80-Thr84 in
molecules related by non-crystallographic two-fold symmetry. mHRF is coloured purple, and hHRF structures are coloured green [PDB 1YZ1 (Susini et al., 2008)] and yellow [PDB 3EBM
(Dong et al., 2009)]. (D) The overall positions of the two molecules diﬀer in the mHRF and hHRF crystal structures. mHRF and hHRF structures were superposed on one of the two
molecules related by non-crystallographic two-fold symmetry (grey), and the second molecule is coloured as follows: mHRF (purple), PDB 1YZ1 (green) and PDB 3EBM (yellow). Lys130
from one chain, and Asn131 and Gln133 from the other are labeled for structures 1YZ1 and 3EBM. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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is conserved. In chain A of the hHRF-2 structure, residues Asn42-Thr62
of the mobile loop are disordered, similar to that seen in mHRF. By
contrast, only residues Arg38-Gly49 are disordered in chain B; this
chain contains the greatest number of mobile loop residues modeled in
any HRF crystal structure to date. However, in chain B, the ordered
base of the mobile loop does not form a β-sheet, and the conformation
of the main chain diﬀers from other hHRF structures (Fig. 4A). The
overall position of the ordered part of the mobile loop in this chain also
diﬀers from those observed in the hHRF solution structure (Feng et al.,
2007), and is stabilized by packing interactions with symmetry-related
molecules (Fig. 4B). These interactions include: a hydrogen bond be-
tween the Ala52 main chain and Glu22 side chain (from chain B of a
symmetry-related molecule), two hydrogen bonds between the Ala54
main chain and Ile20 main chain (from chain B of a symmetry-related
molecule), packing of Gly61 against His77, with a hydrogen bond be-
tween the Gly61 main chain and Glu138 (from chain A of a symmetry-
related molecule), and packing of Thr65 against the C-terminal His-tag
(from chain B of a symmetry-related molecule).
The diﬀerent mobile loop conformations observed in the monomeric
hHRF solution structure (Feng et al., 2007) are incompatible with the
hHRF-2 crystal structure lattice due to clashes with symmetry-related
molecules, or the other molecule of the asymmetric unit. It is unclear
whether the conformation of the partially ordered mobile loop in chain
B of the hHRF-2 structure would be adopted in solution, but this
structure adds to our understanding of the ﬂexibility of the mobile loop
by deﬁning a new, accessible conformation.
3.4. hHRF-2 contains a disulphide-linked dimer
hHRF contains two cysteine residues, at positions 28 and 172, and
Cys172 is suggested to be responsible for disulphide bond-mediated
dimerisation (Kim et al., 2009); notably, Cys172 is surface exposed,
while Cys28 is buried, in the structure of the hHRF monomer. In the
hHRF-2 structure, the two molecules of the asymmetric unit are related
to one another by non-crystallographic two-fold symmetry, and contain
an intermolecular disulphide bond between Cys172 from each chain
(Figs. 5A and 5B).
The interface between the two molecules includes the following
contacts: the base of the two mobile loops (residues 34–39 in chain A
and 33–37 in chain B) pack against one another; Met1 from one chain
Fig. 2. hHRF-1. (A) Overall structure of hHRF-1 solved at 1.75 Å resolution. The two
molecules of the asymmetric unit are coloured blue and salmon. The C-terminal tag is
coloured yellow and the positions of C-terminal residues, and residues adjacent to the
disordered loop, are indicated. (B) The two monomers of the asymmetric unit (blue and
salmon) bury a surface area of ∼530 Å2 at their interface. (For interpretation of the re-
ferences to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
Fig. 3. hHRF-2. (A) Overall structure of hHRF-2, solved at 1.4 Å resolution. The two
molecules of the asymmetric unit are coloured blue and pink. For each structure, the C-
terminal tag is coloured yellow and the positions of C-terminal residues, and residues
adjacent to the disordered loop, are indicated. (B) The two monomers of the hHRF dimer
(blue and pink) bury a surface area of ∼954 Å2 at their interface (∼666 Å2 if the C-
terminal His-tag is omitted from the structure). (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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contacts Met1, Ile3 and Glu12 from the other; Ile17 packs against
Asn75 and His76, while Met74 packs against the mobile loop; fur-
thermore, a single water molecule forms two hydrogen bonds, one with
Asn75 in each chain. The disulphide bond between Cys172 in each
chain is accommodated in a shallow depression created by the Met1
and Ile3 side chains (Fig. 3B). Due to the two-fold symmetrical nature of
Fig. 4. The hHRF mobile loop. (A) In chain B of the hHRF-2 structure, the mobile loop conformation diﬀers from that in the hHRF solution structure, and partially ordered loops in other
hHRF crystal structures. Structures are coloured as follows: hHRF NMR structure (PDB 2HR9, 20 conformers), grey (Feng et al., 2007); hHRF crystal structure (PDB 1YZ1, four chains),
green (Susini et al., 2008); hHRF crystal structure (PDB 3EBM, four chains), yellow (Dong et al., 2009); hHRF-1 structure chain A, pale blue; hHRF-1 structure chain B. teal; hHRF-2
structure chain A, pale pink; hHRF-2 structure chain B, dark pink. For clarity, C-terminal tags are not shown. (B) The mobile loop from chain B of the hHRF-2 structure packs against a
symmetry-related dimer. Chains A and B of the hHRF-2 structure are coloured pink and grey, respectively, and loop residues are shown as sticks. Electron density is shown for the loop
from chain B (2FoFc map contoured at 1σ). Symmetry-related molecules are coloured in pale orange and blue, and the C-terminal tag is coloured yellow. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. Disulphide-linked hHRF dimers. (A) Disulphide-linked dimer of hHRF-2. The two monomers are coloured blue and pink. Residues 50–68 from the mobile loop in chain B (blue)
have been omitted for clarity. (B) View of the hHRF-2 dimer after a 90° rotation towards the reader. (C) Disulphide-linked dimer from PDB 3EBM (Dong et al., 2009). The two monomers
are coloured green and yellow. (D) View of the 3EBM dimer after a 90° rotation towards the reader. The position of Cys172, involved in inter-chain disulphide bond formation, is
indicated for each structure. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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the interaction, the interface is similar for each chain, but not identical
due to the diﬀerent conformation of the mobile loop in chain B.
Only one other HRF structure [human HRF containing a Glu12Val
mutation (PDB 3EBM)], contains a dimer covalently linked by a dis-
ulphide bond (Dong et al., 2009). In this structure, in which the two
monomers are also related by non-crystallographic two-fold symmetry
(Figs. 5C and D), Met1 contacts Glu170 from the other chain, residues
His77 from each chain pack against one another, and additionally form
a hydrogen bond with Glu138 from the other chain. The disulphide
bond is more exposed than in the hHRF-2 structure, and packs against
Met1, Ile3 and Glu170. Notably, Glu12 is found at the dimer interface
in wild-type HRF (hHRF-2 structure), its side chain forming a water-
mediated bridging hydrogen bond with the second monomer. By con-
trast, the two monomers are arranged diﬀerently in the Glu12Val mu-
tant dimer, and Val12 would be unable to form a comparable hydrogen
bond.
Wild-type hHRF described here, and the Glu12Val hHRF mutant,
both contain a C-terminal puriﬁcation tag (Leu173-His180), and in each
dimer the tag in one chain contacts the other monomer; however, this
interaction diﬀers between the two structures. In the structure of the
Glu12Val hHRF mutant (Dong et al., 2009), the Leu173 main chain
forms hydrogen bonds with the Lys171 main chain, while His175 packs
against Ile2, Met169 and Lys171 from the other monomer. By contrast,
in the wild-type structure hHRF-2, a water molecule forms bridging
hydrogen bonds between Leu173 main chain atoms, while His175
packs against Glu170. In chain B of the hHRF-2 structure, Glu174 packs
against Arg5, while His177 packs against His10 (Glu174 is partially
disordered in chain A, and in each chain the overall conformation of the
tag diﬀers after His176).
The interface between the two molecules of the Glu12Val hHRF
mutant buries a surface area of ∼652 Å2, of which 40% is contributed
by the C-terminal His-tag. By contrast, the interface in hHRF-2 buries a
substantially larger surface area, ∼954 Å2, of which a smaller propor-
tion, ∼25%, is contributed by the tag. Thus, the two molecules in the
wild-type hHRF-2 dimer are much more closely associated with one
another, compared with the mutant (Figs. 5A-D), and we propose that
this new structure reﬂects the native dimeric and functionally active
state with respect to mast cell activation.
3.5. hHRF-2 structure reveals a model for the role of HRF in mast cell
activation
The current model for the activity of HRF in mast cell activation is
that dimeric HRF cross-links FcεRI-bound IgE on the mast cell surface,
mediated by interactions between HRF and the Fab regions of a subset
of IgE molecules (Kawakami et al., 2014). IgE binding sites on HRF,
which interact with the Fabs, have been mapped to the N-terminal re-
gion (residues 1–19) and helix 3 (residues 107–135) (Kashiwakura
et al., 2012). HRF can form a disulphide-linked dimer, mediated by
Cys172 (Kim et al., 2009), and the dimer is able to bind to IgE
(Kashiwakura et al., 2012).
The hHRF-2 structure comprises a wild-type hHRF dimer, with a
disulphide bond between Cys172 from each monomer. In this dimer,
the two monomers are closely associated, burying a surface area of
∼666 Å2 if the C-terminal His-tag is omitted from the structure.
Crucially, the two binding sites necessary for the Fab interactions are
surface exposed in each molecule (Fig. 6), and would thus enable cross-
linking of FcεRI-bound IgE to occur. Furthermore, the human and
murine proteins are 96% identical, and the residues involved in forming
both the disulphide bond and dimer interface are identical. We there-
fore propose that the hHRF-2 structure provides a model for the activity
of both human and murine HRF in mast cell activation.
4. Conclusions
We report the ﬁrst crystal structure of murine HRF and the structure
of human HRF in two new crystal forms, one at the highest resolution
yet reported. The high resolution human HRF structure contains a
disulphide linked dimer, with closely packed monomers, which pro-
vides a model for the activity of human and murine HRF in allergic
disease.
Accession numbers
Coordinates and structure factors have been deposited in the Protein
Data Bank with accession numbers: mHRF, PDB: 5O9K; hHRF-1 PDB
5O9L; hHRF-2, PDB 5O9M.
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